PDA stent better than APS for initial palliation in patients with congenital heart disease: JAHA Dr. Hiral patel19 Sept 2022 10:00 PM ISTUSA: In cyanotic congenital heart disease with ductal-dependent pulmonary blood flow, a patent ductus arteriosus (PDA) stent is associated with fewer...
Ouick weight loss linked to lowered CKD risk among men with NAFLD: Study Dr. Kamal Kant Kohli19 Sept 2022 8:30 PM ISTCHINA: According to a study published in the journal Obesity, patients with obesity and high blood pressure may experience a lower risk of developing...
FDA approves Rolvedon for chemotherapy induced febrile neutropenia Dr. Kamal Kant Kohli19 Sept 2022 8:00 PM ISTThe Food and Drug Administration (FDA) has approved Rolvedon (eflapegrastim-xnst) to decrease febrile neutropenia among adults with nonmyeloid...
Second-hand smoke exposure a likely risk factor for developing asthma for future generations Dr. Kamal Kant Kohli19 Sept 2022 8:00 PM ISTAccording to a new study, Children are more prone to develop asthma if their father was exposed to second-hand smoke when he was a child.The study...
Digital adherence tools cost effective for improving adherence to anti-TB therapy and QoL: JAMA Jacinthlyn Sylvia19 Sept 2022 8:00 PM ISTMedication event reminder monitor (MERM)-observed treatment improved patients' health-related quality of life and had reduced catastrophic costs...
Ganglion cell complex thinning to predict vision-related QoL in glaucoma: JAMA Dr. Hiral patel19 Sept 2022 8:00 PM ISTUSA: The faster and sectoral central location of ganglion cell complex (GCC) thinning helps determine the risk of vision-related quality of life in...
Pegcetacoplan as effective as eculizumab in paroxysmal nocturnal haemoglobinuria: Lancet Dr. Shravani Dali19 Sept 2022 8:00 PM ISTPegcetacoplan is as efficacious as eculizumab in paroxysmal nocturnal haemoglobinuria according to a recent study published in the Lancet. In the...
Secukinumab effective for treating pityriasis rubra pilaris: Study Jacinthlyn Sylvia19 Sept 2022 8:00 PM ISTUSA: Secukinumab is a good therapy with favorable outcomes for pityriasis rubra pilaris (PRP) and deserves more research, suggests an article...
Double dose influenza vaccination may not improve cardiopulmonary outcomes in acute coronary syndrome Jacinthlyn Sylvia19 Sept 2022 8:00 PM ISTBrazil: A new study conducted by Henrique Andrade R Fonseca and his team showed that receiving two doses of the influenza vaccine before discharge did...
Taurine holds potential as new treatment for diabetes, suggests study Medha Baranwal19 Sept 2022 8:00 PM ISTChina: In diabetes patients, taurine supplementation improves glycemic indices, such as fasting blood sugar, HbA1c, and HOMA-IR, however, it has no...
Is NT-proBNP reliable for heart failure diagnosis in Indian patients? Study provides insights Medha Baranwal19 Sept 2022 7:30 PM ISTMaharashtra: NT-proBNP can help diagnose heart failure (HF) but only in addition to clinical findings, a recent study published in the Journal of the...
Booster dose of Malaria vaccine after three-dose regimen effective against clinical malaria Dr. Shravani Dali19 Sept 2022 11:00 AM ISTMalaria vaccine is still effective against spread of malaria according to a recent study published in the Lancet Infectious Diseases Malaria is a...
